Sehhoon Park
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Developing Artificial Intelligence-based Algorism to Predict Side Effects and Symptoms From Chemotherapy (NCT05937477) | Sehhoon Park | 2023-06-08 |
| Lazertinib for NSCLC Harboring Activating EGFR Mutations in TKI naïve Patients (NCT05463224) | Sehhoon Park | 2023-01-04 |
| Efficacy and Safety of 80mg Osimertinib in Patients With Non-small Cell Lung Cancer(NSCLC) (NCT04563871) | Sehhoon Park | 2020-11-17 |
Track Sehhoon Park automatically
Every clearance here is in the API, with alerts when new ones post.